Abstract:Background Bromodomain is an evolutionally conserved domain that is found in proteins strongly implicated in signal-dependent transcriptional regulation. Genetic alterations of bromodomain genes contributed to the development of many human cancers and other disorders. BRD7 is a recently identified bromodomain gene. It plays a critical role in cellular growth, cell cycle progression, and signal-dependent gene expression. Previous studies showed that BRD7 gene exhibited much higher-level of mRNA expression in normal nasopharyngeal epithelia than in nasopharyngeal carcinoma (NPC) biopsies and cell lines. However, little is known about its transcriptional regulation. In this study, we explored the transcriptional regulation of BRD7 gene. Method Potential binding sites of transcription factors within the promoter region of BRD7 gene were predicted with MatInspector Professional http://genomatix.de/cgi-bin/matinspector_prof/mat_fam.pl . Mutation construct methods and luciferase assays were performed to define the minimal promoter of BRD7 gene. RT-PCR and western blot assays were used to detect the endogenous expression of transcription factor Sp1, c-Myc and E2F6 in all cell lines used in this study. Electrophoretic mobility shift assays (EMSA) and Chromatin immunoprecipitation (ChIP) were used to detect the direct transcription factors that are responsible for the promoter activity of BRD7 gene. DNA vector-based siRNA technology and cell transfection methods were employed to establish clone pools that stably expresses SiRNA against c-Myc expression in nasopharyngeal carcinoma 5-8F cells. Real-time PCR was used to detect mRNA expression of BRD7 gene in 5-8F/Si-c-Myc cells. Results We defined the minimal promoter of BRD7 gene in a 55-bp region (from -266 to -212bp), and identified that its promoter activity is inversely related to c-Myc expression. Sp1 binds to the Sp1/Myc-Max overlapping site of BRD7 minimal promoter, and slightly positively regulate its promoter activity. c-Myc binds to this Sp1/Myc-Max overlapping site as well, and negatively regulates the promoter activity and endogenous mRNA expression of BRD7 gene. Knock-down of c-Myc increases the promoter activity and mRNA level of BRD7 gene. The luciferase activity of the mutated promoter constructs showed that Sp1/Myc-Max overlapping site is a positive regulation element of BRD7 promoter. Conclusion These studies provide for the first time the evidence that c-Myc is indeed a negative regulator of BRD7 gene. These findings will help to further understand and uncover the bio-functions of BRD7 gene involved in the pathogenesis of NPC.

Transcriptional regulation of BRD7 expression by Sp1 and c-Myc

Cloning and characterization of the BRD7 gene promoter.

Promoter Methylation Inhibits BRD7 Expression in Human Nasopharyngeal Carcinoma Cells

Tumor suppressor bromodomain-containing protein 7 cooperates with Smads to promote transforming growth factor-β responses

BRD7 Expression and C-Myc Activation Forms a Double-Negative Feedback Loop That Controls the Cell Proliferation and Tumor Growth of Nasopharyngeal Carcinoma by Targeting Oncogenic Mir-141

Cloning and Functional Characterization of the Regulation Region of Human Brd7 Gene

BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways.

The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain

BRD7, a Novel Bromodomain Gene, Inhibits G1–S Progression by Transcriptionally Regulating Some Important Molecules Involved in Ras/mek/erk and Rb/E2F Pathways

Overexpression of E2F6 Gene Inhibits Promoter Activity of BRD7 Gene

Sp1 and c-Myc regulate transcription of BMI1 in nasopharyngeal carcinoma.

BRD7 Suppresses the Growth of Nasopharyngeal Carcinoma Cells (HNE1) Through Negatively Regulating Β-Catenin and ERK Pathways

BRD7 Inhibits Enhancer Activity and Expression of BIRC2 to Suppress Tumor Growth and Metastasis in Nasopharyngeal Carcinoma

miR-141 is involved in BRD7-mediated cell proliferation and tumor formation through suppression of the PTEN/AKT pathway in nasopharyngeal carcinoma

[Expression of BRD7-interacting Proteins,brd2 and BRD3, in Nasopharyngeal Carcinoma Tissues].

[Researching a Novel NPC-related Candidate Suppressor Gene BRD7 by Two-Dimensional Gel Electrophoresis and MALDI-TOF-MS].

Identification of Nuclear Localization Signal That Governs Nuclear Import of BRD7 and Its Essential Roles in Inhibiting Cell Cycle Progression

The Epigenetic Modifier PRDM5 Functions As a Tumor Suppressor Through Modulating WNT/β-catenin Signaling and is Frequently Silenced in Multiple Tumors.

CircBRD7 Attenuates Tumor Growth and Metastasis in Nasopharyngeal Carcinoma Via Epigenetic Activation of Its Host Gene.

A Positive Feedback Loop Between EBP2 and C-Myc Regulates Rdna Transcription, Cell Proliferation, and Tumorigenesis.

BRD7 Promotes Cell Proliferation and Tumor Growth Through Stabilization of c-Myc in Colorectal Cancer